Health Reference LibraryCyanocobalamin B12 drops: the stable, standard form and when it makes sense
This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Summary
Cyanocobalamin is the synthetic, most stable form of vitamin B12 and the form used in the majority of B12 research, and the body converts cyanocobalamin into both active coenzymes, methylcobalamin and adenosylcobalamin, a conversion that works well for most people. The NIH Office of Dietary Supplements states no B12 form has demonstrated better supplement absorption, so the honest case here is stability and value rather than potency, and where methylcobalamin degrades in light, cyanocobalamin holds its strength reliably in the bottle. Each drop provides 98mcg, giving fine dose control from a maintenance drop to a multi-drop routine, and a blood result below 180 ng/L under NICE NG239 belongs with a GP rather than self-supplementation.
How it works
Cyanocobalamin is cobalamin stabilised with a cyanide group in trace, pharmacologically irrelevant quantity, giving the molecule its exceptional shelf stability. After absorption, the body strips that group and converts the cobalamin into methylcobalamin for the cytoplasmic methylation pathway and adenosylcobalamin for the mitochondrial energy pathway, as demand dictates. This conversion works reliably for the great majority of people, which is why cyanocobalamin performed as the standard form across decades of B12 research.
Effective dose
Intrinsic factor saturates at roughly 1.5 to 2mcg per dose, and higher intakes rely on passive absorption of about 1 to 2 percent per the NIH Office of Dietary Supplements. One 98mcg drop covers the 1.5mcg daily reference intake several times over through the active pathway alone, making a single daily drop a genuine maintenance dose. For a high-dose oral routine comparable to 1000mcg capsules, ten drops delivers the equivalent, and the bottle format makes that arithmetic simple. Correcting confirmed deficiency is GP-led under NICE NG239.
Forms compared
The liquid provides 98mcg of cyanocobalamin per single drop in a purified water base, with cyanocobalamin as the sole B12 form. The stability advantage is real and practical, since methylcobalamin and adenosylcobalamin are light sensitive and degrade in storage while cyanocobalamin holds potency reliably. Drops suit people who dislike capsules, want a child-of-the-house-friendly format on GP advice, or want doses between the standard capsule sizes.
Timing
B12 can be taken at any time, with or without food. Drops under the tongue held briefly before swallowing is a common habit, though the evidence for meaningful sublingual absorption over simple swallowing is thin and the passive-absorption arithmetic works either way. Consistency matters more than method.
Safety profile
B12 has no established upper intake limit because toxicity has not been demonstrated at supplemental doses. The trace cyanide in cyanocobalamin is far below any level of concern at supplement doses; the one exception in clinical practice involves rare inherited cobalamin defects and heavy smokers with specific eye disease, where clinicians choose hydroxocobalamin, decisions that sit with specialists. Fatigue with numbness, pins and needles, a sore tongue or memory changes needs a blood test and GP before supplementing, because supplementing first can mask a deficiency needing proper workup.
Special populations
Vegans and vegetarians need a reliable B12 source and cyanocobalamin drops are among the most economical. Roughly 21 percent of adults over 60 show at least one abnormal B12 biomarker per the NIH ODS, and absorption of food-bound B12 declines with age, making a supplement sensible territory for older adults with GP awareness. Metformin and long-term acid suppression reduce food-bound B12 absorption, a testing prompt. People with kidney failure are a specialist case where hydroxocobalamin is often preferred.
Interactions
Metformin and acid-suppressing drugs reduce absorption of food-bound B12 over time. High-dose folate can normalise the blood picture while B12-related nerve damage continues, so B12 status comes first before high-dose folate. Nutri365 checks for interactions and contraindications across the full supplement and lifestyle picture when you use the platform.
Guideline positions
The NIH Office of Dietary Supplements (2025) states no oral B12 form has demonstrated superior absorption, documents intrinsic factor saturation at 1.5 to 2mcg and roughly 1 to 2 percent passive absorption at high doses, and notes cyanocobalamin as the form in most supplements and research. NICE NG239 (2024) sets total B12 below 180 ng/L as deficient with 180 to 350 indeterminate, and the NHS manages non-dietary deficiency with hydroxocobalamin injections every 2 to 3 months for life.
Practical framework
Choose cyanocobalamin when you want dependable, economical B12 with fine dose control and shelf stability, the sensible default for maintenance in vegans, older adults and anyone without a specific reason to pick a coenzyme form. Vitamin B12 Cyanocobalamin provides 98mcg per drop at £22.68 for the bottle, in stock and UK-made, at nutritailor.co.uk/products/vitamin-b12-cyanocobalamin. One drop daily is genuine maintenance; ten drops matches a 1000mcg high-dose routine. A result below 180 ng/L or any neurological symptoms means GP first.
Common misconceptions
The cyanide in cyanocobalamin is a persistent scare story, but the quantity is a trace far below any toxicological concern at supplement doses, and decades of research used exactly this form. Another misconception is that active forms absorb better; the NIH ODS states absorption does not differ by form, and the body converts cyanocobalamin to both coenzymes. Finally, drops are often assumed weaker than capsules, when the arithmetic per microgram is what matters and the drop format simply divides the dose differently.
Sources
- NIH Office of Dietary Supplements 2025. Vitamin B12 Fact Sheet for Health Professionals. NIH ODS.
- NICE 2024. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). NICE.
- NHS 2024. Vitamin B12 or folate deficiency anaemia: treatment. NHS.